These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
240 related articles for article (PubMed ID: 8144120)
1. [What are the indications for proton pump inhibitors? R. Arnold, Marburg, elaborates on the clinical aspects of the controversy regarding lansoprazole. Interview by Gerrit Lichtenberg]. Arnold R Fortschr Med; 1994 Jan; 112(1-2):44-5. PubMed ID: 8144120 [No Abstract] [Full Text] [Related]
2. [Proton pump inhibitor for ulcer therapy. Tolerance profile of lansoprazole]. Müller P; Fuchs W; Peifer-Weiss A; Simon B Fortschr Med; 1998 Oct; 116(28):31-2. PubMed ID: 9844264 [No Abstract] [Full Text] [Related]
3. Human gastric carcinoid detected during long-term antiulcer therapy of H2 receptor antagonist and proton pump inhibitor. Haga Y; Nakatsura T; Shibata Y; Sameshima H; Nakamura Y; Tanimura M; Ogawa M Dig Dis Sci; 1998 Feb; 43(2):253-7. PubMed ID: 9512115 [No Abstract] [Full Text] [Related]
4. [Lansoprazole--profile of a new proton pump inhibitor]. Seifert E Leber Magen Darm; 1994 Mar; 24(2):66-8, 71. PubMed ID: 8196467 [TBL] [Abstract][Full Text] [Related]
5. [Lansoprazol]. Ponce J; Nos P Gastroenterol Hepatol; 1995 Feb; 18(2):101-9. PubMed ID: 7621274 [No Abstract] [Full Text] [Related]
9. Lansoprazole: a comprehensive review. Zimmermann AE; Katona BG Pharmacotherapy; 1997; 17(2):308-26. PubMed ID: 9085323 [TBL] [Abstract][Full Text] [Related]
10. Omeprazole. Med Lett Drugs Ther; 1990 Mar; 32(813):19-21. PubMed ID: 2179694 [No Abstract] [Full Text] [Related]
11. Drug therapy of peptic ulcer disease. Ching CK; Lam SK Br J Hosp Med; 1995 Jul 12-Aug 15; 54(2-3):101-6. PubMed ID: 7551483 [TBL] [Abstract][Full Text] [Related]
12. Treatment of patients with Zollinger-Ellison syndrome. Mignon M; Pospai D; Forestier S; Vatier J; Vallot T Clin Ther; 1993; 15 Suppl B():22-31. PubMed ID: 8205592 [TBL] [Abstract][Full Text] [Related]
13. Suppression of Acid Secretion by Lansoprazole and its Effects on Helicobacter pylori. II. Poster presentations from the 2nd International Colloquium on Proton Pump Inhibitors. Houston, Texas, September 29, 1994. J Clin Gastroenterol; 1995; 20 Suppl 2():S1-135. PubMed ID: 7594319 [No Abstract] [Full Text] [Related]
14. [Indications and use of omeprazole in esophago-gastro-duodenal diseases]. Martín de Argila C; Boixeda de Miquel D; Moreira Vicente V; García Plaza A Rev Clin Esp; 1999 Nov; 199(11):729-39. PubMed ID: 10638238 [No Abstract] [Full Text] [Related]
15. [Risk for developing tumors in therapy with the proton pump inhibitor omeprazole]. Eissele R; Arnold R Versicherungsmedizin; 1993 Aug; 45(4):126-9. PubMed ID: 8379045 [TBL] [Abstract][Full Text] [Related]
16. Lansoprazole and omeprazole in the treatment of acid peptic disorders. Blum RA Am J Health Syst Pharm; 1996 Jun; 53(12):1401-15. PubMed ID: 8781686 [TBL] [Abstract][Full Text] [Related]
17. Lansoprazole versus omeprazole in the treatment of reflux esophagitis. Vcev A; Stimac D; Vceva A; Rubinić M; Ivandić A; Ivanis N; Horvat D; Volarić M; Karner I Acta Med Croatica; 1997; 51(3):171-4. PubMed ID: 9248117 [TBL] [Abstract][Full Text] [Related]
18. [Proton pump blockers and their significance in gastroenterology]. Dítĕ P; Prásek J Vnitr Lek; 1995 Aug; 41(8):549-54. PubMed ID: 7483340 [TBL] [Abstract][Full Text] [Related]
19. [Lansoprazol ++ : a new proton pump inhibitor]. Baczek J; Laskowiec G Pol Merkur Lekarski; 1998 Jun; 4(24):339-41. PubMed ID: 9771021 [TBL] [Abstract][Full Text] [Related]